Dexcom finds CGM use helps people with Type 2 diabetes stay in range
https://medcitynews.com/2021/10/dexcom-points-to-more-data-on-cgm-use-for-type-2-diabetes/
https://medcitynews.com/2021/10/dexcom-points-to-more-data-on-cgm-use-for-type-2-diabetes/
https://medcitynews.com/2021/10/dexcom-points-to-more-data-on-cgm-use-for-type-2-diabetes/
https://medcitynews.com/2021/10/healthcare-organizations-remain-at-risk-despite-proper-hipaa-compliance/
https://medcitynews.com/2021/10/health2047s-new-company-plans-to-use-ai-research-access-to-improve-clinical-decision-making/
https://medcitynews.com/2021/10/clinical-trials-vendor-trialspark-raises-156m-to-transform-into-a-drug-company/
https://medcitynews.com/2021/10/the-future-is-digital-reimagining-patient-engagement/
https://medcitynews.com/2021/09/feds-provide-payment-resolution-process-in-new-surprise-billing-rule/
https://medcitynews.com/2021/09/two-alphabet-subsidiaries-come-together-as-onduo-sends-fitbits-to-some-of-its-users/
https://medcitynews.com/2021/09/googles-deepmind-faces-suit-over-access-to-nhs-patient-records/
https://medcitynews.com/2021/09/merck-to-buy-acceleron-for-11-5b-cardio-drug-could-cushion-fall-from-keytruda-cliff/